The evaluation of the German Paul-Ehrlich-Institut has been completed for our Rapid Test Ag 2019-nCov, which has been assessed as reflecting the current state of the art regarding its diagnostic sensitivity.
The evaluation aimed to compare different rapid Covid-19 antigen tests with using identical sample material. Among the laboratories that participated in this comparative evaluation were the Robert Koch-Institut, Charité (the reference laboratory for coronaviruses), and the Institute for Microbiology of the German Army (Bundeswehr).
To get the full report please contact: info@prognosis-biotech.com
